Neurocrine Biosciences (NBIX) Revenue
Market Cap: $10.26B
Avg Volume: 1.33M
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
What is Neurocrine Biosciences's Revenue?
Neurocrine Biosciences's quarterly revenue as of Q4 2024 is $627.70M.
Neurocrine Biosciences's annual revenue for the fiscal year 2024 is $2.36B.
Related metrics for Neurocrine Biosciences (quarterly):
- Cost of Revenue: $9.30M
- Gross Profit: $618.40M
- Gross Profit Ratio: 98.52%
- Revenue Per Share: $6.25
- Revenue Growth: 0.90%
Apple's quarterly revenue was $627.70M, with a cost of revenue of $9.30M, which leaves $618.40M gross profit and a gross profit ratio of 98.52%.
Related metrics for Neurocrine Biosciences (annual):
- Cost of Revenue: $34.00M
- Gross Profit: $2.32B
- Gross Profit Ratio: 98.56%
- Revenue Per Share: $23.46
- Revenue Growth: 24.81%
Apple's annual revenue was $2.36B, with a cost of revenue of $34.00M, which leaves $2.32B gross profit and a gross profit ratio of 98.56%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2024.
| Year | Revenue | Change |
|---|---|---|
| 2024 | $2.36B | 24.81% |
| 2023 | $1.89B | 26.76% |
| 2022 | $1.49B | 31.34% |
| 2021 | $1.13B | 8.38% |
| 2020 | $1.05B | 32.71% |
| 2019 | $788.10M | 74.65% |
| 2018 | $451.24M | 179.19% |
| 2017 | $161.63M | 977.51% |
| 2016 | $15.00M | -24.12% |
| 2015 | $19.77M | N/A |
| 2014 | $- | -100.00% |
| 2013 | $2.92M | -94.51% |
| 2012 | $53.14M | -31.36% |
| 2011 | $77.41M | 131.08% |
| 2010 | $33.50M | 1034.47% |
| 2009 | $2.95M | -25.71% |
| 2008 | $3.98M | 224.75% |
| 2007 | $1.22M | -96.88% |
| 2006 | $39.23M | -68.33% |
| 2005 | $123.89M | 45.45% |
| 2004 | $85.18M | -38.76% |
| 2003 | $139.08M | 670.73% |
| 2002 | $18.05M | -56.25% |
| 2001 | $41.24M | 182.71% |
| 2000 | $14.59M | -13.17% |
| 1999 | $16.80M | 5.00% |
| 1998 | $16.00M | -38.70% |
| 1997 | $26.10M | 35.94% |
| 1996 | $19.20M | N/A |
Related Metrics
Explore detailed financial metrics and analysis for NBIX.